^
Association details:
| Biomarker: | NF2 mutation |
|---|---|
| Cancer: | Mesothelioma |
| Drug: | Visudyne (verteporfin) (Reactive oxygen species stimulant, Photosensitizer) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Integrated genomics point to immune vulnerabilities in pleural mesothelioma
Published date:
09/27/2021
Excerpt:
...RASSF7 amplifcation and NF2 or LATS1/2 mutations were present in 50% of tumours and were accompanied by micromolar responses to the YAP1 inhibitor Verteporfn.
DOI:
https://www.nature.com/articles/s41598-021-98414-w
